XML 61 R47.htm IDEA: XBRL DOCUMENT v3.22.2
SHARE-BASED PAYMENTS - Schedule of Share-based Compensation, Restricted Stock, Restricted Stock Units Activity and SAR's (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Apr. 18, 2022
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based Payment Arrangement, Expense   $ 1,147 $ 489 $ 2,009 $ 1,190  
Weighted Average Grant Date Fair Value            
Common stock, shares, outstanding (in shares)   157,569,420   157,569,420   156,262,199
Common stock, shares, issued (in shares)   157,569,420   157,569,420   156,262,199
Share capital Common shares, without par value, unlimited shares authorized; shares issued and outstanding 157,569,420 at June 30, 2022 and 156,262,199 at December 31, 2021   $ 695,404   $ 695,404   $ 685,903
Equity Option            
Weighted Average Grant Date Fair Value            
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)       $ 1.34 $ 0.94 $ 0.94
Nonvested, weighted average grant date fair value, end of period (in dollars per share)   $ 4.17   $ 4.17   $ 1.34
Employee Stock Option            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based Payment Arrangement, Expense   $ 109 37 $ 141 $ 240  
Weighted Average Grant Date Fair Value            
Unrecognized Compensation Costs Related To Unvested Stock Options       460    
Restricted Stock Units (RSUs)            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based Payment Arrangement, Expense   $ 488 390 $ 972 $ 753  
Number of Shares            
Granted, nonvested, number of shares (in shares) 20,000.00     350,000 440,000  
Weighted Average Grant Date Fair Value            
Unrecognized Compensation Costs Related To R S U Awards       $ 1,820    
Restricted Stock Units (RSUs) | Equity Option            
Number of Shares            
Number of nonvested shares, beginning of period (in shares)       900,064 1,094,056 1,094,056
Granted, nonvested, number of shares (in shares)       354,406   441,241
Vested, number of shares (in shares)       (518,856)   (635,233)
Forfeited, number of shares (in shares)       (42,082)    
Number of nonvested shares, end of period (in shares)   693,532   693,532   900,064
Weighted Average Grant Date Fair Value            
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)       $ 2.94 $ 1.98 $ 1.98
Granted, nonvested, weighted average grant date fair value (in dollars per share)       6.59   3.89
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value       5.34    
Vested, weighted average grant date fair value (in dollars per share)       2.93   1.94
Nonvested, weighted average grant date fair value, end of period (in dollars per share)   $ 4.66   $ 4.66   $ 2.94
Stock Appreciation Rights (SARs)            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based Payment Arrangement, Expense   $ 550 $ 62 $ 896 $ 197  
Number of Shares            
Number of nonvested shares, beginning of period (in shares)       1,672,422 1,720,623 1,720,623
Granted, nonvested, number of shares (in shares)       833,315    
Exercised, number of shares (in shares)       (6,730)   (48,201)
Forfeited, number of shares (in shares)       (34,921)    
Number of nonvested shares, end of period (in shares)   2,464,086   2,464,086   1,672,422
Weighted Average Grant Date Fair Value            
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)       $ 2.92 $ 2.92 $ 2.92
Granted, nonvested, weighted average grant date fair value (in dollars per share)       6.47    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercised, Weighted Average Exercise Price       2.92   2.92
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value       5.79    
Nonvested, weighted average grant date fair value, end of period (in dollars per share)   $ 4.08   $ 4.08   $ 2.92
Unrecognized Compensation Costs Related To R S U Awards       $ 2,300    
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Number   1,092,143   1,092,143    
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price   $ 2.92   $ 2.92    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms       2 years 6 months 18 days    
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Remaining Contractual Term       1 year 6 months 21 days    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding   $ 3,301   $ 3,301    
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Aggregate Intrinsic Value   $ 2,173   $ 2,173    
Stock Appreciation Rights (SARs) | Equity Option            
Number of Shares            
Number of nonvested shares, beginning of period (in shares)       573,549 1,720,623 1,720,623
Granted, nonvested, number of shares (in shares)       833,315    
Vested, number of shares (in shares)           (1,147,074)
Forfeited, number of shares (in shares)       (34,921)    
Number of nonvested shares, end of period (in shares)   1,371,943   1,371,943   573,549
Weighted Average Grant Date Fair Value            
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)       $ 1.19 $ 1.25 $ 1.25
Granted, nonvested, weighted average grant date fair value (in dollars per share)       3.99    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value       4.05    
Vested, weighted average grant date fair value (in dollars per share)           1.27
Nonvested, weighted average grant date fair value, end of period (in dollars per share)   $ 2.83   $ 2.83   $ 1.19